CBPO [China Biologic Products] 6-K: China Biologic Reports Financial Results for the Third
[China Biologic Reports Financial Results for the Third Quarter of 2018 3Q18 Total Sales Up 21.9% YoY in RMB terms, or 19.6% YoY in USD terms; Non-GAAP Adjusted Net Income Down 12.7% YoY in RMB terms; Net Income Up 4.1% YoY to $32.9 Million Board of Directors Approves $100 Million Share Repurchase Pr]